Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression

ConclusionsOur findings illuminate oxymatrine as an effective antitumor agent in renal cell carcinoma, and suggest it a promising therapeutic application in renal cell carcinoma treatment.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research